Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
about
Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease.Persistent Inflammation, Stem Cell-Induced Systemic Anti-Inflammatory Effects, and Need for Repeated Stem Cell Injections: Critical Concepts Influencing Optimal Stem Cell Strategies for Treating Acute Myocardial Infarction and Heart Failure.Therapeutic Use of Stem Cells for Myocardial Infarction.Inverse opal substrate-loaded mesenchymal stem cells contribute to decreased myocardial remodeling after transplantation into acute myocardial infarction mice
P2860
Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
@ast
Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
@en
type
label
Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
@ast
Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
@en
prefLabel
Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
@ast
Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
@en
P2860
P356
P1476
Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
@en
P2093
Maria Dorobantu
P2860
P356
10.4252/WJSC.V9.I4.68
P407
P577
2017-04-26T00:00:00Z